CLOLAR
Live / Registered — Registered and renewed (as of 29 Jan 2016)
What this means for you
Registered since 29 Nov 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Nov 2015).
Record
- Serial number
- 78381186
- Registration number
- 3021950
- Mark type
- Stylized text
- Filed
- 09 Mar 2004
- Published for opposition
- 19 Apr 2005
- Registered
- 29 Nov 2005
- Next maintenance due
- 29 Nov 2015
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer and autoimmune disease in the field of oncology
Owner
- GENZYME CORPORATION, Cambridge, MA, US
- GENZYME CORPORATION, CAMBRIDGE, MA, US
- ILEX Products, Inc., San Antonio, TX, US
- ILEX Products, Inc., San Antonio, TX, US
Prosecution history
- 29 Nov 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jan 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Jan 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 29 Jan 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Jan 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Nov 2015 — TEAS SECTION 8 & 9 RECEIVED
- 18 Feb 2011 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Feb 2011 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Feb 2011 — TEAS SECTION 8 & 15 RECEIVED